home / stock / sva:cc / sva:cc news

SVA:CC News and Press, Sernova Corp. From 09/22/22

Stock Information
Company Name: Sernova Corp.
Stock Symbol: SVA:CC
Market: TSXVC
Website: sernova.com
Menu
SVA:CC SVA:CC Quote SVA:CC Short SVA:CC News SVA:CC Articles SVA:CC Message Board
Get SVA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
SVA:CC - Sernova Announces Full Exercise of Share Purchase Warrants Expiring September 22, 2022

LONDON, Ontario, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE / XETRA:PSH), a clinical-stage company and leader in regenerative cell therapeutics, today announced that all remaining share purchase warrants related to the 2020 private placement, expiring on S...
SVA:CC - Sernova to Present at H.C. Wainwright Annual Global Investment Conference and LifeSci Partners HealthTech Symposium

LONDON, Ontario, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced it will be presenting at the upcoming H.C. Wainwright 24 th Annual Global Investment...

SVA:CC - Sernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of Directors

- Successful biopharma entrepreneur with 25 years of experience growing leading healthcare firms - LONDON, Ontario, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeut...

SVA:CC - Sernova Receives Second Tranche Equity Investment from Evotec of $6.8 Million at a Price of $2.50 Per Share

LONDON, Ontario, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/ XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that it has completed the second and final tranche of its previously announced private ...
SVA:CC - Sernova to Participate in Live Investor Event Hosted by Leede Jones Gable, Inc.

LONDON, Ontario, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that Dr. Philip Toleikis, President & CEO of Sernova Corp, will participate in a fire...

SVA:CC - Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June

LONDON, Ontario, June 15, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that Dr. Philip Toleikis, President & CEO of Sernova Corp, will be participating in t...

SVA:CC - Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System(TM) at American Diabetes Association 82nd Scientific Sessions 2022

Researchers from the Dr. Piotr Witkowski Laboratory at the University of Chicago presented updated data on six patients with type 1 diabetes and hypoglycemia unawareness The first three patients have been insulin independent for over 2 years, 6 months, and 3 months, respective...
SVA:CC - Sernova Opens the Market

Sernova Opens the Market Canada NewsWire TORONTO , June 2, 2022 /CNW/ - Dr. Philip Toleikis , President and Chief Executive Officer, Sernova Corp. (TSXV: SVA) and his team joined Tanya Rowntree , Global Head of Client Success, Toronto Stock Exchan...

SVA:CC - SERNOVA SHARES to Commence Trading on TSX On June 2, 2022

(TheNewswire) London, Ontario – TheNewswire - June 1 , 2022 – Sernova Corp. (TSXV:SVA ) ; ( OTC:SEOVF ) ; ( FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeut...

SVA:CC - Sernova Receives Conditional Approval to Up-list to the Toronto Stock Exchange

(TheNewswire) London, Ontario – TheNewswire - May 24 , 2022 – Sernova Corp. (TSXV:SVA; ) ( OTC:SEOVF ) ; ( FSE: PSH); ( XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell t...
Previous 10 Next 10